Navigation Links
Gene test shows which bladder cancer patients may have cancer spread
Date:1/20/2011

AURORA, Colo. (Jan. 20, 2011)--Cancer scientists have designed the first molecular test to predict which bladder cancer patients may have cancer involvement in their lymph nodes at the time of surgerywhich could help doctors determine which patients are good candidates for pre-surgical, or neo-adjuvant, chemotherapy.

The test analyzes 20 genes on tumor biopsies, according to a paper published online Jan. 20, 2011, in Lancet Oncology.

"Randomized clinical trials have shown that giving neo-adjuvant chemotherapy extends patient lives, but only 5 to 15 percent of patients benefit," says urologic surgeon Dan Theodorescu, MD, PhD, director of the University of Colorado Cancer Center and lead author of the study. "Patients who have cancer in the lymph nodes at time of diagnosis are likely to benefit the most."

The study analyzed patient tumor samples from the United States, Canada and Germany. It was funded by the National Cancer Institute.

"Today, only about 2 percent of people with invasive bladder cancer have pre-surgical chemotherapy because it's quite difficult to get through and there is fear of delaying surgery," Theodorescu says. "We need a better way to predict who will benefit, and that's what this test does by identifying patients with a high likelihood of lymph node involvement before surgery."

By the time a third of people are diagnosed, bladder cancer has invaded from the bladder lining into the bladder muscle. Gold-standard treatment includes surgical removal of the bladder and the surrounding lymph nodes; some people also undergo radiation treatment. Even with these treatments, the cancer will recur and spread in about half the peoplewhich is almost always fatal.

Bladder cancer is diagnosed during a procedure called a transurethral resectionessentially a biopsy of the bladder. Using the new test, pathologists can determine the levels for the 20 genes in the diagnostic tissue sample and indicate whether the patient has cancer in the lymph nodes.

"We validated the test's ability to predict lymph node spread of the cancer in a large sample of patients from a randomized trial," said Theodorescu. "The predictive ability held up. If this new test is used to guide neo-adjuvant chemotherapy, we hope it will both help people with positive nodes live longer and keep people with negative nodes from being overtreated."

A clinical trial of using the test as a treatment guide is being planned.


'/>"/>

Contact: Caitlin Jenney
caitlin.jenney@ucdenver.edu
303-328-5720
University of Colorado Denver
Source:Eurekalert

Related medicine news :

1. First blinded study of venous insufficiency prevalence in MS shows promising results
2. People with anxiety disorder less able to regulate response to negative emotions, study shows
3. Poll Shows Eroding Support for Health Reform
4. Protecting patients: Study shows that Johns Hopkins flu vaccination rates twice national average
5. Compound shows promise against intractable heart failure
6. Drama or reality TV: Do medical shows depict proper first aid for seizures?
7. TV Shows Often Botch Proper Seizure Responses
8. UQ research shows canecutters disease on the rise among travelers
9. Brain Scan Shows What Beauty is Worth
10. Untreated poor vision in elderly linked to dementia, University of Michigan study shows
11. New research shows emotional impact of low sexual desire and associated distress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... ... journal and most-read publication among specialty pharmacists and pharmacy professionals, has teamed ... Strategic Alliance Partnership (SAP) program, announced Brian Haug, president of Pharmacy Healthcare ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... that their Vice President of Franchise Development, Paula Turner Pizarro, was recently featured ... program, which features the insights of top business leaders from across the globe, ...
(Date:1/18/2017)... , ... January 18, 2017 , ... At Hallmark Nameplate, ... announce that they have achieved certification to ISO 13485. This certification is another way ... up to date products and services that they need. , The ISO 13485 Certification ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... company, launched a new website for its Center for Biosimilars, announced Michael J. ... the latest developments in the field of biosimilars through thought leader interaction in, ...
(Date:1/18/2017)... ... January 18, 2017 , ... During pregnancy, ... to enamel erosion, and those dental problems can increase the risk of pregnancy ... pregnant women are failing to get the dental care they need. Agoura Hills ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 2017  Robust competition in the private marketplace ... medicine prices, according to a new study ... among the first to examine the share of prescription ... benefit managers (PBMs), health plans and other stakeholders in ... the first to show what happens when the list ...
(Date:1/17/2017)... , Jan. 17, 2017 North America Insulin ... new report, "North America Insulin Delivery Market Outlook to ... Insulin Delivery market. The report provides value, in millions ... (USD) within market segments - Insulin Pens, Insulin Pumps, ... report also provides company shares and distribution shares data ...
(Date:1/17/2017)... Research and Markets has announced the addition of the ... their offering. ... This new report revisits the market potential for self-healing materials from ... 2015. Self-healing is an area of smart coatings and materials with ... potential of $2.7 billion ($US) by 2020. However, in any market ...
Breaking Medicine Technology: